Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$657M |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$587M |
| 4 |
AstraZeneca
AZN
|
+$319M |
| 5 |
Snowflake
SNOW
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$323M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$273M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$121M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$98.6M |
| 5 |
JD.com
JD
|
+$89.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.03% |
| 2 | Financials | 13.72% |
| 3 | Healthcare | 12.6% |
| 4 | Consumer Discretionary | 10.97% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DVAX
2226
DELISTED
Dynavax Technologies
DVAX
| $1.07M | ﹤0.01% |
55,951
+24,469
| +78% | +$325K |
|
|
SCS
2227
DELISTED
Steelcase
SCS
| $1.07M | ﹤0.01% |
84,735
-23,812
| -22% | -$328K |
|
2228
UiPath
PATH
$7.8B
| $1.07M | ﹤0.01% |
+20,261
| New | +$1.23M |
|
2229
SiTime
SITM
$21.8B
| $1.06M | ﹤0.01% |
5,210
+3,298
| +172% | +$588K |
|
|
BLUE
2230
DELISTED
bluebird bio
BLUE
| $1.06M | ﹤0.01% |
4,283
+1,024
| +31% | +$293K |
|
2231
Phibro Animal Health
PAHC
$1.39B
| $1.06M | ﹤0.01% |
49,222
+4,075
| +9% | +$98.1K |
|
2232
Brookdale Senior Living
BKD
$3.4B
| $1.06M | ﹤0.01% |
167,876
-75,366
| -31% | -$538K |
|
2233
Traeger
COOK
$172M
| $1.05M | ﹤0.01% |
+1,007
| New | +$1.26M |
|
2234
VEON
VEON
$3.95B
| $1.05M | ﹤0.01% |
20,168
+16,108
| +397% | +$775K |
|
|
LADR
2235
Ladder Capital
LADR
$1.24B
| $1.05M | ﹤0.01% |
94,751
-8,407
| -8% | -$94.1K |
|
2236
Mercer International
MERC
$39.8M
| $1.04M | ﹤0.01% |
90,085
+8,870
| +11% | +$103K |
|
|
FSP
2237
Franklin Street Properties
FSP
$46.8M
| $1.04M | ﹤0.01% |
224,048
-565,794
| -72% | -$2.76M |
|
|
ANAT
2238
DELISTED
American National Group, Inc. Common Stock
ANAT
| $1.04M | ﹤0.01% |
5,493
+1,594
| +41% | +$283K |
|
2239
NovaGold Resources
NG
$3.33B
| $1.04M | ﹤0.01% |
149,906
-381
| -0.3% | -$2.82K |
|
2240
Atara Biotherapeutics
ATRA
$76.1M
| $1.03M | ﹤0.01% |
2,311
+561
| +32% | +$201K |
|
|
DCPH
2241
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.03M | ﹤0.01% |
30,456
+7,919
| +35% | +$253K |
|
2242
Gates Industrial Corporation Ltd.
GTES
$7.15B
| $1.03M | ﹤0.01% |
63,509
+56,608
| +820% | +$969K |
|
2243
Goosehead Insurance
GSHD
$2.32B
| $1.03M | ﹤0.01% |
6,780
+4,117
| +155% | +$555K |
|
2244
V2X
VVX
$2.65B
| $1.03M | ﹤0.01% |
20,527
+2,297
| +13% | +$109K |
|
2245
American Well
AMWL
$230M
| $1.03M | ﹤0.01% |
5,654
+464
| +9% | +$101K |
|
2246
ChargePoint
CHPT
$161M
| $1.03M | ﹤0.01% |
2,573
+2,226
| +641% | +$1.04M |
|
|
YSG
2247
Yatsen Holding
YSG
$319M
| $1.03M | ﹤0.01% |
53,893
+16,651
| +45% | +$508K |
|
2248
REX American Resources
REX
$1.41B
| $1.01M | ﹤0.01% |
76,158
+6,396
| +9% | +$86.4K |
|
2249
Prothena Corp
PRTA
$450M
| $1M | ﹤0.01% |
14,082
+6,095
| +76% | +$379K |
|
2250
KB Financial Group
KB
$43.5B
| $999K | ﹤0.01% |
21,512
| – | – |
|
Similar funds
Legal & General Group's Q3 2021 Portfolio in Review
As of Q3 2021, Legal & General Group held 3,551 positions worth $308B, up 2.9% from $299B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Legal & General Group deployed $10.7B of net new capital in Q3 2021, opening 77 new positions and adding to 2,293 existing holdings. Its largest new stake was AstraZeneca: 2,738,007 shares worth $329M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was JD.com, an estimated $89.3M trimmed.
- Legal & General Group's largest Q3 2021 buy was AstraZeneca: 2,738,007 shares worth $329M.
- Legal & General Group added most to Microsoft in Q3 2021, an estimated $657M increase.
- Legal & General Group's biggest Q3 2021 reduction was JD.com, cutting an estimated $89.3M.
- Legal & General Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $323M.
- Legal & General Group's ten largest holdings make up 22% of its $308B portfolio in Q3 2021.
- Legal & General Group opened 77 new positions and closed 55 in Q3 2021.
- Legal & General Group's portfolio value rose 2.9% quarter-over-quarter to $308B.
Based on Legal & General Group's 13F filing for Q3 2021, filed 15 Nov 2021.